首页> 外文期刊>International braz j urol >Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis
【24h】

Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis

机译:部分肾切除术提供相同的肿瘤结果和比自由基肾细胞癌的激进肾功能术,肾功能保存更好:荟萃分析

获取原文
           

摘要

Purpose: Radical nephrectomy (RN) is the standard surgical type for pathological stage T3a (pT3a) renal cell carcinoma (RCC). Recently, some studies have suggested equivalence between partial nephrectomy (PN) and RN for oncologic control and have shown the benefits of PN for better renal function. We conducted this meta-analysis to assess oncologic outcomes, perioperative outcomes and renal function between two groups among patients with pT3a RCC. Materials and methods: PubMed, Scopus, Web of Science, Science Direct, Ovid MEDLINE, The Cochrane Library, Embase and Google Scholar were searched for eligible articles. The endpoints of the final analysis included overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), surgical complications, operative time, estimated blood loss (EBL), serum creatinine and estimated glomerular filtration rate (eGFR). Results: Twelve studies of moderate to high quality, including 14.152 patients, were examined. PN showed superiority for renal functional preservation, providing higher eGFR (WMD=12.48mL/min; 95%CI: 10.28 to 14.67; P 0.00001) and lower serum creatinine (WMD=-0.31mg/dL; 95%CI: ?0.40 to ?0.21; P 0.00001). There were no significant differences between PN and RN regarding operative time, EBL, surgical complications, OS, RFS and CSS. Despite inherent selection bias, most pooled estimates were consistent in sensitivity analysis and subgroup analysis. More positive margins were found in the PN group (RR=2.42; 95%CI: 1.25-4.68; P=0.009). Conclusions: PN may be more suitable for treating pT3a RCC than RN because it provides a similar survival time (OS or RFS) and superior renal function. Nevertheless, this result is still disputed, and more high-quality studies are required.
机译:目的:自由基肾切除术(RN)是病理阶段T3A(PT3A)肾细胞癌(RCC)的标准外科手术型。最近,一些研究表明部分肾切除术(PN)和肿瘤控制的RN之间的等效性,并显示了PN的益处以获得更好的肾功能。我们进行了这种荟萃分析,以评估PT3A RCC患者两组之间的肿瘤结果,围手术期结果和肾功能。材料和方法:PubMed,Scopus,科学网,科学直接,Ovid Medline,Cochrane图书馆,Embase和Google学者被搜查了符合条件的文章。最终分析的终点包括整体存活(OS),癌症特异性存活(CSS),可复发存活(RFS),手术并发症,手术时间,估计的血液丧失(EBL),血清肌酐和估计的肾小球过滤速率( EGFR)。结果:检查了12项中度至高品质的研究,包括14.152名患者。 PN显示出肾功能保存的优势,提供更高的EGFR(WMD = 12.48ml / min; 95%CI:10.28至14.67; P <0.00001)和下血清肌酐(WMD = -0.31mg / DL; 95%CI:?0.40到?0.21; p <0.00001)。 PN和RN有关手术时间,EBL,手术并发症,OS,RF和CSS之间没有显着差异。尽管选择偏差是固有的选择,但大多数汇总估计在敏感性分析和子组分析中是一致的。在PN组中发现了更多的阳性边缘(RR = 2.42; 95%CI:1.25-4.68; P = 0.009)。结论:PN可能更适合于治疗PT3A RCC而不是RN,因为它提供了类似的存活时间(OS或RFS)和优异的肾功能。然而,这一结果仍然有争议,并且需要更高质量的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号